Results 181 to 190 of about 1,625,584 (294)
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Analysing Spatiotemporal Characteristics and Estimating the Spatial Distribution of Peste des Petits Ruminants (PPR) in Africa. [PDF]
Chai R, Zhang S, Joka DL.
europepmc +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Characterizing Amyloid Pathogenic Spread in Alzheimer's Disease Through A Network Diffusion Model. [PDF]
Xu FH +7 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Lumbar Interlaminar Ventral Epidural Injection Without Catheter at L5-S1 for Lumbosacral Radicular Pain: A Pilot Feasibility Study. [PDF]
Park J, Lee S, Lee S, Lim C, Kim Y.
europepmc +1 more source
First In Situ Seismic Record of Spreading Events at the Ultraslow Spreading Southwest Indian Ridge [PDF]
Michaela Meier, Vera Schlindwein
openalex +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

